AUXILIUM PHARMACEUTICALS INC's ticker is AUXL and the CUSIP is 05334D107. A total of 153 filers reported holding AUXILIUM PHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is 0.34 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2014 | $6,096,000 | -90.2% | 177,293 | -91.5% | 0.00% | -88.2% |
| Q3 2014 | $62,114,000 | +41.4% | 2,080,848 | -5.0% | 0.02% | +41.7% |
| Q2 2014 | $43,933,000 | -1.2% | 2,190,023 | +33.8% | 0.01% | 0.0% |
| Q1 2014 | $44,487,000 | +29.2% | 1,636,768 | -1.4% | 0.01% | +20.0% |
| Q4 2013 | $34,426,000 | +15.4% | 1,659,888 | +1.4% | 0.01% | +11.1% |
| Q3 2013 | $29,833,000 | +7.8% | 1,636,488 | -1.6% | 0.01% | 0.0% |
| Q2 2013 | $27,669,000 | – | 1,663,788 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 4,883,879 | $101,243,000 | 9.44% |
| Tamarack Capital Management, LLC | 1,250,000 | $25,913,000 | 6.14% |
| Healthcare Value Capital, LLC | 334,481 | $6,934,000 | 5.09% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,113,385 | $85,270,000 | 4.42% |
| KING INVESTMENT ADVISORS INC/TX | 312,890 | $6,486,000 | 2.96% |
| Broadfin Capital, LLC | 961,100 | $19,924,000 | 2.63% |
| SECTOR GAMMA AS | 462,504 | $9,588,000 | 2.59% |
| TAMRO Capital Partners LLC | 1,898,717 | $39,360,000 | 1.62% |
| Elk Creek Partners, LLC | 84,090 | $1,743,000 | 1.25% |
| Artal Group S.A. | 1,500,000 | $31,095,000 | 1.12% |